Back to All Companies

Quest Diagnostics, Inc. | Company Profile, Marketing Contacts, Media Spend, Brands

Quest Diagnostics, Inc. is a corporation which provides clinical laboratory testing and services. The company has operations in the U.S. the U.K., Mexico and India. Quest Diagnostics, Inc. is headquartered in Lindhurst, NJ.

Main Telephone (913) 888-1770
Main Fax (913) 888-0771
Primary Address
10101 Renner Boulevard
Lenexa, KS 66219-9752

Quest Diagnostics, Inc. Contacts

Contacts (5/17)
Name Title State
Gary S. Vice President & Chief Communications Officer NJ
Sample of Associated Brands
Email: *****@*******.***
Main Phone: (973) 520-2700
Direct Phone: *** **** ***   ext: ****
Direct Fax: *** **** ***
Assistant Name: ** **** ***
Assistant Phone: *** **** ***
Address: 10101 Renner Boulevard
Lenexa, KS

Bill B. Vice President, Purchasing & Chief Procurement Officer NJ
Stephen R. President & Chief Executive Officer NJ
Lidia F. Chief Information Officer & Senior Vice President NJ
Mark G. Chief Financial Officer & Executive Vice President, Finance NJ

Media Spend

Media Spend Summary
Media Spend Channel

Associated Brands

Brand Media Spend
Quest Diagnostics, Inc. ******
Quest Direct *

Agency Relationships

Brand Agency Service From To
***** ***********, ***. ***** ****** ********* public relations 2009 present
***** ***********, ***. ****** & **** creative 2009 present

See Winmo sales intelligence in action

Recent Discussions

Who is the Vice President & Chief Communications Officer of Quest Diagnostics, Inc.?

Who is the marketing contact for medical laboratories in NJ

What is the email of the Vice President, Purchasing & Chief Procurement Officer of Quest Diagnostics, Inc.?

What is direct phone of the President & Chief Executive Officer of Quest Diagnostics, Inc.?

Who is the public relations agency of Quest Diagnostics, Inc.?

Your personal LinkedIn network connections

Your personal LinkedIn network connections


Quest Diagnostics buys Athena Diagnostics

The Story
Quest Diagnostics, Inc., a global leader in diagnostic testing, information and services, announced that it has signed a definitive agreement to acquire Athena Diagnostics, an esoteric laboratory, from its parent company Thermo Fisher Scientific, Inc.
For the purchase price of $740 million in an all-cash transaction, Madison, N.J.-based Quest Diagnostics will now benefit from Athena Diagnostics’ services, which include genetic testing for neurological disorders.
Athena Diagnostics is the leading provider of advanced diagnostic tests used to either confirm or disprove physicians’ diagnoses of neurological conditions like Alzheimer’s disease, neuromuscular disorders like Spinal Muscular Atrophy and developmental disorders.
Based in Worcester, Mass., Athena provides a comprehensive test menu and intellectual property portfolio for neurological conditions through more than 350 diagnostic tests.
Quest Diagnostics offers access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff.
Serving both patients and doctors, Quest Diagnostics led the way with developing diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
The Research
Athena Diagnostics will establish the company as a true leader in this emerging market of neurological testing that represents the next significant growth area for diagnostics.
“Athena’s leadership in neurology, including its robust product pipeline and intellectual property assets, will complement Quest Diagnostics’ existing leadership in testing for cancer, infectious disease and cardiovascular disease,” said Dr. Surya Mohapatra, chairman and chief executive officer of Quest Diagnostics.
In 2010, Athena Diagnostics generated about $110 million in revenue, and is growing at a rapid rate. This purchase agreement is expected to close early in the second quarter of 2011, so long as it adheres to customary conditions.
“We expect to further accelerate Athena’s growth by supplementing its specialty sales organization with Quest Diagnostics’ extensive sales force, to sell into our broader customer base,” Mohapatra continued.
He added that Quest Diagnostics is confident that Athena will be seen as the primary provider for diagnostic testing as new and earlier therapies are developed for neurological conditions like Alzheimer’s disease.
Should the close date arrive as expected, Athena is slated to add about 1 percent to Quest Diagnostics’ 2011 revenue growth. Quest plans to finance the transaction initially with cash on hand and available credit facilities.
Thermo Fisher Scientific’s Vice President of Corporate Communications Karen Kirkwood told WinmoEdge that since the acquisition was just signed, she felt it was a bit too premature to address any marketing-related questions in detail.
“I know that Athena has marketed its services in the past through its direct relationships with physicians,” she said. “I don't imagine that this overall strategy will change much, but any questions about marketing strategy will be for the new owner, Quest, after the close.”
Kirkwood added that the most exciting aspect of this deal is the close alignment that Athena has with Quest as a contract lab services provider, which will offer excellent opportunities for growth.
Parsippany, N.J.-based Siegel+Gale has helped with strategic branding efforts since 2009.
The Nielsen Company reported that Quest Diagnostics spent about $100,000 on national advertising efforts in 2009. About $70,000 was spent on B-to-B initiatives, about $30,000 was allocated to local magazine ads and about $2,000 was put toward spot television commercials.
The Nielsen Company also reported that Athena Diagnostics’ current parent company, Thermo Fisher Scientific, Inc., spent $1.2 million on media in 2009. About $100,000 was put toward B-to-B efforts, $10,000 toward outdoor ads and about $3,000 toward Internet ads.

Quest Diagnostics, Inc.
3 Giralda Farms
Madison, NJ 07940
(973) 520-2700
Peter Wilkinson
Director, Marketing
(913) 888-1770
Surya N. Mohapatra, Ph.D.
Chairman & Chief Executive Officer
(973) 520-2700

Athena Diagnostics, Inc.
Four Biotech Park
377 Plantation Street
Worcester, MA 01605
(508) 756-2886
Arthur Boyce
Vice President, Sales & Marketing
(508) 756-2886

Amy Winslow
Vice President, Marketing
(508) 756-2886
Robert Flaherty
President & Chief Executive Officer
(508) 756-2886